Beiersdorf's Derma Brands Drive Growth Amid Portfolio Challenges
Beiersdorf's Derma division, led by Eucerin and Aquaphor, posted 10.6% organic sales growth in Q3 2026, contrasting with a 1.3% group-wide decline as the Nivea business faced continued pressure.

Beiersdorf's Derma business posted 10.6% organic sales growth in the third quarter of 2026. This surge, driven by Eucerin and Aquaphor, provided a bright spot against a 1.3% organic decline in the group's overall net revenue, which totaled 2.36 billion euros. The Derma division's growth reached 8.7% for the first nine months of the year, with sales hitting 1.24 billion euros. Meanwhile, the company's consumer sales fell 0.7% organically to 1.94 billion euros.
Aquaphor's U.S. rise
Aquaphor's expansion into the U.S. body care market proved a notable success. Its launch, which began in July 2026, saw the brand reach the number three position in the therapeutic skincare market within just six weeks. It also became the top Derma body-care brand in the U.S. drugstore channel. The brand grew 13% organically during the quarter.
Eucerin's clinical innovation
Eucerin reinforced its clinical positioning with the launch of Dermopure Clinical Probiom8. The new solution for acne-prone skin is based on patented cosmetic active ingredients and microbiome research.
La Prairie's mixed picture
La Prairie posted 8.5% organic sales growth in the quarter, accelerating after earlier retail disruptions. China was the principal growth driver, with net sales there rising 28%. The brand's White Caviar line became the top luxury brightening collection in China following the addition of Thiamidol. In September, La Prairie launched Swiss Pristine, a new entry-level line priced from 180 to 300 euros aimed at attracting younger consumers. Buyers of this line are on average four to 10 years younger than existing clients, and 80% are new to the brand. The launch has enabled distribution through Amazon in the U.S. and Sephora and Bluemercury in Canada. Despite the strong quarter, La Prairie's nine-month organic sales declined 2.2% to 342 million euros.
Nivea and Fa under pressure
The company's Grand Public segment, led by Nivea, continued to face challenges. Nivea and Labello organic sales declined 4.9% in the quarter, though this was an improvement from the 6.7% decline in the previous quarter. Excluding Russia, the decline was 3.2%. Retailer disputes, inventory reductions, and sales phasing weighed on performance. A commercial dispute involving a Russian subsidiary also affected the quarter, though normal operations have since resumed. Within the segment, sun-care sell-out grew 6%, and deodorants returned to growth, but face care remained weak. In Western Europe, Nivea's sell-out was slightly positive, increasing roughly 1% through August.
Beiersdorf is pursuing a turnaround plan for Nivea and Fa centered on portfolio expansion. Initiatives include the European rollout of the FACE+ range, priced between five and six euros and containing ingredients like vitamin C and hyaluronic acid. Early results showed strong recruitment of new consumers. In India, Nivea is expanding its Soft range into gel moisturizers. The company expects the fourth quarter to remain slightly negative as inventory normalization continues. Beiersdorf confirms its 2026 forecasts, anticipating a single-digit organic sales decline for the Grand Public segment and the group overall. The company said "the repositioning of the brand begins to bear fruit."





